Cervical Cancer Trials
Select Clinical Trial
Regeneron R2810-ONC-1676/GOG 3016 (CVP 1601) - An Open-Label, Randomized, Phase 3 Clinical Trial of REGN2810 Versus Therapy of Investigator's Choice Chemotherapy in Recurrent or Metastatic Platinum-Refractory Cervical Carcinoma
- Women, ages 18 or older, with progression or recurrence of cervical cancer